MCM3 and prostate carcinoma: MCM3 is highly expressed in diverse types of malignancies, including breast cancer (Lokkegaard et al., 2021), ovarian cancer (Li et al., 2021), colorectal cancer (Zhou et al., 2020), and prostate cancer (Hsu et al., 2021).